
    
      In this randomized, controlled, parallel study we will comparison total neoadjuvant therapy
      with standard neoadjuvant therapy in rectal cancer treatment. Complete pathological response
      rate will be the primary endpoint in patients, who will undergoing surgery. In cases of
      complete clinical response we will provide "watch and wait" approach. Compliance of treatment
      and oncologic results will be the second endpoint.
    
  